Sarcoma Surgeries: Oncological Outcomes and Prognostic Factors
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Surgical Oncology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 507
Special Issue Editor
Special Issue Information
Dear Colleagues,
Soft tissue sarcomas (STSs) are rare malignant tumors of mesenchymal origin. The World Health Organization describes more than 80 different histological subtypes of sarcomas. STSs most commonly arise in the extremities, whereas retroperitoneal locations occur in 15% of cases. The mainstay treatment for STSs remains surgery. Completeness of resection has been shown to improve survival outcomes in numerous studies. Understanding the unique pathological and anatomical characteristics of sarcoma subtypes can guide surgical oncologists to perform appropriate surgeries.
Various factors have been shown to influence oncological outcomes: from achieving precise biopsies for accurate diagnosis to prompt referral to sarcoma experts are key elements to improve outcomes. Performing a complete resection and offering adjuvant treatments for selected patients are essential to optimize survival. This Special Issue of Current Oncology will focus on sarcoma surgery, from the preoperative steps to postoperative surveillance. It will address intraoperative challenges and discuss prognostic factors determining survival.
Dr. Mai-Kim Gervais
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sarcoma
- surgery
- resection
- prognostic factors
- survival
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
